JD Supra5d
FDA Approves the First Flu Vaccine for At Home Use, Providing a Needle Free Option Outside of Traditional Health Care Settings
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
PBS1d
Why getting your flu and COVID-19 vaccines before the holidays is a good idea
Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — they’re not just another dose of ...
MM&M23h
AstraZeneca: New drug data, promising earnings and a $3.5B R&D investment
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Nasal Spray Could Delay Alzheimer's by Years
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Neuroscience News6d
New Nasal Spray Could Delay Alzheimer’s Progression by Years
Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...
Nasal spray made from stem cell-derived vesicles could treat Alzheimer's disease
A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...
FiercePharma2d
With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...